MedPath

Evaluation of Leg Muscular Activity Using MRI and 11C-acetate PET/MRI. Pilot Study

Phase 1
Conditions
Healthy
Interventions
Other: Magnetic Resonance combined with Positron Emission Tomography
Other: Magnetic Resonance Imaging
Registration Number
NCT02969603
Lead Sponsor
Osman Ratib
Brief Summary

The present study is conceived as a pilot study aimed to determine the efficiency of the newly available Positron Emission Tomography (PET) - Magnetic Resonance Imaging (MRI) hybrid scan technique for muscular activity evaluation, creation of anatomic images of muscle activity and resolution of metabolic activity distribution within exercising skeletal muscle.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Male
Target Recruitment
10
Inclusion Criteria

MRI exam inclusion criteria

  • Male volunteer aged in the range 18 to 35 years.
  • Acceptance of the research protocol: signature of the informed consent form after oral and written information about the protocol through the patient information document.
  • Volunteers that could undergo 1h15 to 1h30 immobilization (MRI exam duration in time).

PET/MRI exam inclusion criteria

  • Male volunteer aged in the range 18 to 35 years.
  • Acceptance of the research protocol: signature of the informed consent form after oral and written information about the protocol through the patient information document.
  • Volunteers that could undergo 1.5 to 2.0 hours immobilization (PET/MRI exam duration in time).
  • Volunteers should practice regular physical activity, defined as 50 min per day (in a single session), 2 days per week of physical activity as a minimum (no maximum is fixed).

Exclusion criteria MRI exam exclusion criteria

  • Pre-existing neurological or muscular lesions on the legs.
  • Co morbidities impeding on the protocol comprehension or fulfilment.
  • Illnesses that do not allow to lay down on an examination table.
  • Pacemaker holder.
  • Metal implants that would preclude MRI imaging
  • Claustrophobia: Subjects will be questioned about possible discomfort with being in an enclosed space (e.g., MRI scanner). Those who report such problems will be excluded.

PET/MRI exam exclusion criteria

  • Medical radiation exposure within the last five years (normal population should not be exposed to medical radiation higher or equal to 1 mSv per year).
  • Pre-existing neurological or muscular lesions on the legs.
  • Co morbidities impeding on the protocol comprehension or fulfilment.
  • Illnesses that do not allow to lay down on an examination table.
  • Pacemaker holder.
  • Metal implants that would preclude MRI imaging
  • Claustrophobia: Subjects will be questioned about possible discomfort with being in an enclosed space (e.g., MRI scanner). Those who report such problems will be excluded.
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Healthy Volunteers- PET/MRIMagnetic Resonance combined with Positron Emission TomographyThe volunteers will undergo a combined \[11C\]acetate PET/MRI scan
Healthy volunteers- MRIMagnetic Resonance ImagingMRI scan for morphological assessment of muscle structures and anatomy
Primary Outcome Measures
NameTimeMethod
Assessment of musculoskeletal systems in motionthough study completion, an average of 2 years

an informatic visualization tool of muscles implied in leg flexion/extension combining PET and MR infomation

Distribution of acetate metabolism during exercise skeletal musclethough study completion, an average of 2 years

11C-acetate uptake (SUV and SUVratio with resting muscles) in contracting muscle, measured using muscle segmentation from MRI images

Secondary Outcome Measures
NameTimeMethod
Measurement of the in vivo function of the musclethough study completion, an average of 2 years

correlation between 11C-acetate uptake and contractile force measures (weight and duration of exercise)

Trial Locations

Locations (1)

Service de Medecine Nucléaire et Imagerie moléculaire- HUG

🇨🇭

Geneva, Switzerland

© Copyright 2025. All Rights Reserved by MedPath